- Report
- November 2023
- 166 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- February 2024
- 202 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- January 2024
- 213 Pages
Global
From €5313EUR$5,500USD£4,543GBP
- Report
- March 2024
- 197 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- September 2023
- 231 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- January 2024
- 200 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- January 2024
- 155 Pages
Global
From €3509EUR$3,633USD£3,001GBP
€5013EUR$5,190USD£4,287GBP
- Report
- January 2024
- 199 Pages
Global
From €3509EUR$3,633USD£3,001GBP
€5013EUR$5,190USD£4,287GBP
- Report
- February 2024
- 115 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 140 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- October 2023
- 189 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- January 2024
- 200 Pages
Global
From €4009EUR$4,150USD£3,428GBP
- Report
- March 2024
- 163 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- December 2023
- 126 Pages
North America
From €1449EUR$1,500USD£1,239GBP
- Report
- May 2022
- 231 Pages
Global
From €4636EUR$4,799USD£3,964GBP
- Report
- April 2020
- 248 Pages
Global
From €4732EUR$4,899USD£4,047GBP
- Report
- October 2022
- 194 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- April 2020
- 182 Pages
Global
From €3864EUR$4,000USD£3,304GBP
- Report
- July 2020
- 213 Pages
China
From €3091EUR$3,200USD£2,643GBP
- Report
- May 2022
- 109 Pages
Global
From €5313EUR$5,500USD£4,543GBP
The Human Vaccine market is a segment of the larger Vaccine industry, which focuses on the development and distribution of vaccines to protect humans from infectious diseases. Vaccines are typically administered through injections, although some may be administered orally or nasally. Vaccines are designed to stimulate the body's immune system to recognize and fight off a particular disease. Vaccines are typically developed through a combination of laboratory research, clinical trials, and regulatory approval.
The Human Vaccine market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market are focused on developing new vaccines, as well as improving existing vaccines. They are also involved in the production, distribution, and marketing of vaccines.
Some of the major companies in the Human Vaccine market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Johnson & Johnson, and Novartis. Show Less Read more